• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Infect Dis . Intractable COVID-19 and Prolonged SARS-CoV-2 Replication in a CAR-T-cell Therapy Recipient: A Case Study

tetano

Editor, Senior Moderator
Clin Infect Dis


. 2021 Jan 28;ciab072.
doi: 10.1093/cid/ciab072. Online ahead of print.
Intractable COVID-19 and Prolonged SARS-CoV-2 Replication in a CAR-T-cell Therapy Recipient: A Case Study


Matthew K Hensley[SUP] 1 [/SUP], William G Bain[SUP] 1 2 [/SUP], Jana Jacobs[SUP] 3 [/SUP], Sham Nambulli[SUP] 4 5 [/SUP], Urvi Parikh[SUP] 3 [/SUP], Anthony Cillo[SUP] 6 7 [/SUP], Brittany Staines[SUP] 3 [/SUP], Amy Heaps[SUP] 3 [/SUP], Michele D Sobolewski[SUP] 3 [/SUP], Linda J Rennick[SUP] 4 5 [/SUP], Bernard J C Macatangay[SUP] 3 [/SUP], Cynthia Klamar-Blain[SUP] 3 [/SUP], Georgios D Kitsios[SUP] 1 [/SUP], Barbara Meth?[SUP] 1 [/SUP], Ashwin Somasundaram[SUP] 6 8 [/SUP], Tullia Bruno[SUP] 6 [/SUP], Carly Cardello[SUP] 6 [/SUP], Feng Shan[SUP] 6 [/SUP], Creg Workman[SUP] 6 [/SUP], Prabir Ray[SUP] 1 6 [/SUP], Anuradha Ray[SUP] 1 6 [/SUP], Janet Lee[SUP] 1 9 [/SUP], Rahil Sethi[SUP] 10 [/SUP], William E Schwarzmann[SUP] 10 [/SUP], Mark S Ladinsky[SUP] 11 [/SUP], Pamela J Bjorkman[SUP] 11 [/SUP], Dario A Vignali[SUP] 6 [/SUP], W Paul Duprex[SUP] 4 5 [/SUP], Mounzer E Agha[SUP] 8 [/SUP], John W Mellors[SUP] 3 [/SUP], Kevin D McCormick[SUP] 3 [/SUP], Alison Morris[SUP] 1 [/SUP], Ghady Haidar[SUP] 3 [/SUP]



Affiliations

Abstract

A CAR-T-cell recipient developed severe COVID-19, intractable RNAemia, and viral replication lasting >2 months. Pre-mortem endotracheal aspirate contained 2x10 10 SARS-CoV-2 RNA copies/mL and infectious virus. Deep sequencing revealed multiple sequence variants consistent with intra-host virus evolution. SARS-CoV-2 humoral and cell-mediated immunity were minimal. Prolonged transmission from immunosuppressed patients is possible.

Keywords: COVID-19; SARS-CoV-2 RNAemia; SARS-CoV-2 immune responses; SARS-CoV-2 infectivity; SARS-CoV-2 intra-host variation; Severe Acute Respiratory Syndrome Coronavirus-2.
 
Back
Top Bottom